Gertrude Belle Elion was an American biochemist and pharmacologist, born in New York City on January 23, 1918, to a Lithuanian Jewish immigrant dentist and a Polish Jewish immigrant mother. Her family lost its wealth after the Wall Street Crash of 1929, but she graduated from Walton High School at fifteen, was inspired by her grandfather death from stomach cancer to pursue science and medicine, and graduated summa cum laude from Hunter College in 1937 with a degree in chemistry. She saved money to attend New York University and built a career in drug research. She shared the 1988 Nobel Prize in Physiology or Medicine with George H. Hitchings and Sir James Black for innovative methods of rational drug design, which focused on understanding the target of a drug. Her work led to the anti-retroviral drug AZT, the immunosuppressive drug azathioprine and the antiviral drug acyclovir. She was elected a Foreign Member of the Royal Society in 1995 and died on February 21, 1999.
Facts
Field
Field (category) Connections
Member Of
Source Gertrude B. Elion (Wikipedia)
Source Gertrude B. Elion (Wikipedia)
Works In
Source Gertrude B. Elion (Wikipedia)
In the Other Atlases
Nationality
Also in Geography Atlas: the nationality of this subject.
Source Gertrude B. Elion (Wikipedia)Lead, nationalityQuote, Lead, nationality
was an American biochemist and pharmacologist
Sources
1. Gertrude B. Elion (Wikipedia)
Lead
Elion was born in New York City on January 23, 1918
Lead, field
was an American biochemist and pharmacologist
Lead, gender
Her work led to the creation of the anti-retroviral drug AZT
Lead, prize
shared the 1988 Nobel Prize in Physiology or Medicine with George H. Hitchings and Sir James Black
Lead, nationality
was an American biochemist and pharmacologist
Works In: Pharmacology, Lead, discipline
was an American biochemist and pharmacologist
Member Of: New York University, Career, new-york-university
saved up enough money to attend New York University
Member Of: Royal Society, Career, royal-society
She was elected a Foreign Member of the Royal Society (ForMemRS) in 1995
In Group: Physiology And Medicine, Lead, group placement
for their use of innovative methods of rational drug design for the development of new drugs
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.